×
The Standard e-Paper
Informed Minds Prefer The Standard
The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
The United Kingdom has launched the world’s first clinical trial for a personalised cancer vaccine. Unlike traditional vaccines that prevent disease, this immunotherapy targets patients with existing tumours, teaching their immune systems to identify, attack, and prevent the spread of cancer cells.
Subscribe to our newsletter and stay updated on the latest developments and special offers!
join